Knockdown (Micro-RNA Inhibiting Technique) Technique for Evaluation of Alpha-1a Adrenergic Receptor and P2x1 Receptor Functions

  • Posted on: 1 April 2014
  • By: admin

Pharma Admission

Pharma courses

pharma admission

pharma courses

 

PharmaTutor (April- 2014)
ISSN: 2347 - 7881

 

Received On: 11/02/2014; Accepted On: 19/02/2014; Published On: 01/04/2014

 

Author: Emanual Michael Patelia*, Emma Spiking
Department of Pharacology,
University of Bedfordshire, England,
United Kingdom, LU1 3JU
ricky.emanual@gmail.com

 

ABSTRACT:
The new approach regarding the knocking down the protein expression by the use of shmRNA complimentary to the mRNA sequence of the respected protein expression have a major impact on the research area. The knockdown of P2X1 and ADRA1A genes have no effect on chromosomal DNA but have a lack of effect on expression of P2X1 and α1A receptors. The produced genetically engineered male mice can be of 100% infertile. The simple PCR (polymerase chain reaction) based approach can be used for the generation of knockdown cell lines. The Animals should have the treatments according to the guidelines mentioned under international society for applied ethnology. The SIRION biotech have shown the managed shRNA knockdown of about 90% significance interval.

How to cite this article: EM Patelia, E Spiking, Knockdown (Micro-RNA Inhibiting Technique) Technique for Evaluation of Alpha-1A Adrenergic Receptor and P2X1 Receptor Functions, PharmaTutor, 2014, 2(4), 119- 125


[ABSTRACT WITH CITATION]   [VIEW AS HTML]